3-98391146-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005516.1(OR5K3):āc.481G>Cā(p.Glu161Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,614,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E161D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001005516.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5K3 | NM_001005516.1 | c.481G>C | p.Glu161Gln | missense_variant | 1/1 | ENST00000383695.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5K3 | ENST00000383695.1 | c.481G>C | p.Glu161Gln | missense_variant | 1/1 | NM_001005516.1 | P1 | ||
ENST00000508616.1 | n.188+48717G>C | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251218Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135778
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461842Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727234
GnomAD4 genome AF: 0.000295 AC: 45AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.481G>C (p.E161Q) alteration is located in exon 1 (coding exon 1) of the OR5K3 gene. This alteration results from a G to C substitution at nucleotide position 481, causing the glutamic acid (E) at amino acid position 161 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at